Search research articles
Contact Us
Filters
Showing results (61-70 of 140) with videos related to
Page
of 14
Sort By:
Cancer
|
July 1, 1993
Pediatric stage IV Hodgkin disease. Long-term survival
S B Bader, H Weinstein, P Mauch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 4, 2003
Primary systemic treatment of advanced Hodgkin's disease with EVA (etoposide, vinblastine, doxorubicin): 10-year follow-up
G P Canellos, J Gollub, D Neuberg, et al.
Cancer
|
August 1, 1978
The place of radiation therapy in the treatment of Hodgkin's disease
S Hellman, P Mauch, R L Goodman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 5, 2004
Factors influencing treatment recommendations in early-stage Hodgkin's disease: a survey of physicians
A K Ng, S Li, D Neuberg, et al.
Ugeskrift for Laeger
|
November 15, 1993
[Treatment of early stage Hodgkin disease]
L K Specht, P Carde, P Mauch, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 1, 1987
Fractionation and dose rate effects in mice: a model for bone marrow transplantation in man
N J Tarbell, D A Amato, J D Down, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 1, 1990
Renal insufficiency after total body irradiation for pediatric bone marrow transplantation
N J Tarbell, E C Guinan, L Chin, et al.
Hematological Oncology
|
July 1, 1983
Prognostic factors in patients with subdiaphragmatic Hodgkin's disease
P Mauch, H Greenberg, A Lewin, et al.
Leukemia & Lymphoma
|
June 28, 2001
Incidence of post transplant myelodysplasia/acute leukemia in non-Hodgkin's lymphoma patients compared with Hodgkin's disease patients undergoing autologous transplantation following cyclophosphamide, carmustine, and etoposide (CBV)
C Wheeler, A Khurshid, J Ibrahim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 1, 1995
Removal of carcinoma cells from contaminated bone marrow using the lipophilic cation rhodamine 123
J R Wong, C Ho, P Mauch, et al.
Page
of 14
Search research articles
Search
Showing results (61-70 of 140) with videos related to
Sort By:
Page
of 14
Cancer
|
July 1, 1993
Pediatric stage IV Hodgkin disease. Long-term survival
S B Bader, H Weinstein, P Mauch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 4, 2003
Primary systemic treatment of advanced Hodgkin's disease with EVA (etoposide, vinblastine, doxorubicin): 10-year follow-up
G P Canellos, J Gollub, D Neuberg, et al.
Cancer
|
August 1, 1978
The place of radiation therapy in the treatment of Hodgkin's disease
S Hellman, P Mauch, R L Goodman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 5, 2004
Factors influencing treatment recommendations in early-stage Hodgkin's disease: a survey of physicians
A K Ng, S Li, D Neuberg, et al.
Ugeskrift for Laeger
|
November 15, 1993
[Treatment of early stage Hodgkin disease]
L K Specht, P Carde, P Mauch, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 1, 1987
Fractionation and dose rate effects in mice: a model for bone marrow transplantation in man
N J Tarbell, D A Amato, J D Down, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 1, 1990
Renal insufficiency after total body irradiation for pediatric bone marrow transplantation
N J Tarbell, E C Guinan, L Chin, et al.
Hematological Oncology
|
July 1, 1983
Prognostic factors in patients with subdiaphragmatic Hodgkin's disease
P Mauch, H Greenberg, A Lewin, et al.
Leukemia & Lymphoma
|
June 28, 2001
Incidence of post transplant myelodysplasia/acute leukemia in non-Hodgkin's lymphoma patients compared with Hodgkin's disease patients undergoing autologous transplantation following cyclophosphamide, carmustine, and etoposide (CBV)
C Wheeler, A Khurshid, J Ibrahim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 1, 1995
Removal of carcinoma cells from contaminated bone marrow using the lipophilic cation rhodamine 123
J R Wong, C Ho, P Mauch, et al.
Page
of 14